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Abstract
Porcine circovirus 2 (PCV2) is the causative agent of a whole series of diseases in pigs, 
called PCV2 diseases (PCVD). The most relevant of them is the systemic disease (PCV2-SD), 
formerly called post weaning multi systemic wasting syndrome (PMWS). Xenotransplantation 
using pig cells, tissues and organs is under development to overcome the shortage of human 
transplants for the treatment of tissue and organ failure. Xenotransplantation requires functional 
cells, tissues or organs from healthy animals and therefore the donor pigs should be free of 
PCV2. Selection of PCV2-free animals will also prevent transmission of the virus to the human 
recipient. Using a PCR method, (i) Göttingen Minipigs, which are well characterised and which 
were already used in pig to non-human primate xenotransplantations, (ii) newly generated 
Aachen Minipigs, (iii) genetically modified pigs generated for xenotransplantation, (iv) pigs 
from a slaughterhouse and (v) pigs from a German farm were screened for PCV2. 50% of 
the Aachen minipigs and 14% of Göttingen minipigs were PCV2 positive, but the animals were 
apparently healthy. None of the slaughterhouse animals, the farm animals and the genetically 
modified animals were positive for PCV2, because they had been vaccinated. The data indicate 
that PCV2 may be found in healthy pigs even under SPF conditions, and that vaccination is a 
powerful tool to prevent infection. 
ABBREVIATIONS
GAPDH: Glycerinaldehyd-3-phosphat-Dehydrogenase; 
GGTA1: Alpha-Galactosyltransferase 1; HAR: Hyperacute Rejec-
tion; HEV: Hepatitis E Virus; HO1: Heme Oxygenase1; Neu5Gc: 
N-glycolylneuraminic acid; PCV1: Porcine Circovirus 1; PCV2: 
Porcine circovirus 2; PCVD: Porcine Circovirus Diseases; PCVAD: 
Porcine Circovirus Associated Diseases; PCV2-SD: PCV2 Systemic 
Disease; PCV2-LD: PCV2 Lung Disease; PCV2-ED: PCV2 Enteric 
Disease; PCV2-SI: PCV2 Subclinical Infection; PDNS: Porcine Der-
matitis and Nephropathy Syndrome; PCMV: Porcine Cytomega-
lovirus; PMWS: Post weaning Multi systemic Wasting Syndrome; 
CMAH: Cytidine Monophosphate-N-Acetylneuraminic Acid Hy-
droxylase
INTRODUCTION
Porcine circovirus 2 (PCV2) is considered as the essential 
infectious agent of a whole series of diseases in swine which 
are now called porcine circovirus diseases (PCVD) in Europe 
or porcine circovirus associated diseases (PCVAD) in North 
America [1]. The diseases associated with PCV2 are PCV2-SD, a 
systemic disease in piglets, formerly called post weaning multi 
systemic wasting syndrome (PMWS); PCV2-LD, a lung disease, 
previously called proliferative and necrotising pneumonia; 
PCV2-ED, an enteric disease; PCV2-RD, a PCV2-reproductive 
disease; PCV2-subclinical infection (PCV2-SI), and porcine 
dermatitis and nephropathy syndrome (PDNS). PCV2-SD disease 
is characterised by wasting, pale skin, diarrhoea and jaundice, 
PCV2-LD by respiratory distress, PCV2-ED by diarrhoea, PCV2-
RD by stillborn, mummified piglets, and returns to oestrus, PVCV-
SI by a reduced growth rate and PDNS by dark red skin patches 
in hind legs and swollen kidneys. Type and severity of the disease 
depend on the viral subtype, genetic factors of the host and co-
infections [2].
The risk posed by PCV2 for xenotransplantation may be based, 
first of all, on the reduced quality of the transplant due to infection 
and replication of the virus and it may be based, second, on the 
transmission of PCV2 to the human recipient. Viral replication seems 
to take place in a number of cell types of the pig, mainly epithelial 
and endothelial cells as well as macrophages [3], so that most organs 
needed for transplantation may be infected. Since PCV2 suppresses 
innate immunity, concomitant infections are considered a hallmark 
in infection and disease development [4], so that in addition to PCV2 
other zoonotic microorganisms may be transmitted to the recipient. 
Whether direct infection of humans with PCV2 poses a risk for the 
recipient, is still unclear. Whereas human cells can be infected with 
PCV2 resulting in cytopathogenic effects [5], vaccination of humans 
with a live attenuated rotavirus vaccine contaminated with PCV1 or 
PCV2 particles did not result in infection of the vaccinated children 
[6,7].
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The prevalence of PCV2 has been well studied in wild 
boars and breeding herds, however, considerable differences 
in the prevalence in pig herds was observed when analysing 
the literature, ranking from 0.65% to 100% infected (Table 
1). Table (1) compiles the results of 11 studies in over eight 
countries world-wide. Based on these data we were interested 
to analyse the prevalence of PCV2 in pigs which may be used for 
xenotransplantation in comparison with pigs produced for meat 
production. 
MATERIALS AND METHODS 
Animals
The following pig breeds were analysed: First, Göttingen 
Minipigs which were well characterised by the breeding company, 
Ellegaard, Denmark www.minipigs.dk, as well as by our studies 
[8-10]. Second, Aachen Minipigs, a recently established minipig 
breed [11]. Third, genetically modified pigs specially produced 
for xenotransplantation in the Chair of Livestock Biotechnology 
of the Technical University Munich, Germany [12]. The genetic 
modifications with the goal to prevent immunological rejection 
of the xenotransplant included CD55, CD46, and CD59, which 
are all complement regulatory proteins preventing Hyperacute 
Rejection (HAR). In addition, these pigs were expressing HO1 
(heme oxygenase, an enzyme that catalyses the degradation 
of heme) and A20. A20, a zinc finger protein, which has a 
strong antiapoptotic and anti-inflammatory function and over 
expression of A20 in islet cells increased transplant survival [13]. 
The knockout of the alpha-galactosyltransferase 1(GGTA1) (GalT-
KO) and of the cytidine monophosphate-N-acetylneuraminic acid 
hydroxylase (CMAH) abolished expression of the α-Gal and the 
N-glycolylneuraminic acid (Neu5Gc) epitopes [12]. The animals 
were immunised with IngelvacCircoflex (Boehringer Ingelheim). 
In addition, German landrace hybrid pigs, 7 non-transgenic and 
7 expressing INSLEA29Y, which were used in a preclinical trial 
transplanting their islet cells into marmosets [14] were analysed. 
Furthermore, three genetically modified cross-breeds of German 
Landrace and Large White, with a GalT-KO, expressing human 
CD46 and human thrombomodulin, which had been found 
negative for the porcine cytomegalovirus (PCMV) and hepatitis 
E virus (HEV) when tested using sensitive methods and which 
were used as donors for an orthotopic heart transplantation into 
a baboon [15,16] were analysed. Fourth, pigs in a slaughterhouse 
near Berlin and finally, fifth, animals from a farm in Fehmarn, 
Germany were tested. The Fehmarn animals were German 
landrace (sow) crossed with Yorkshire (boar). The animals are 
screened every four and 12 weeks serologically for Actinobacillus 
pleuropneumonia (APP), all 12 weeks for Porcine reproductive 
and respiratory syndrome (PRRS) and mycoplasma by ELISA, 
all 24 weeks for rhinitis, all 12 weeks by PCR for dysentery. 
The animals are vaccinated against PCV2using a vaccine from 
Intervet and against Porcine intestinal adenopathy (PIA), caused 
by Lawsonia intracellularis (Dr. Gripps, ZNVG eG, Neumünster, 
Germany, personal communication). 
DNA isolation
DNA was isolated from either blood, liver or spleen of the 
animals using DN easy blood and tissue kit (Qiagen, Hilden, 
Germany) and from sera using the Pure Link Viral RNA/DNA Mini 
Kit (Life Technologies, Carlsbad, USA). DNA was quantified using 
a Nano Drop spectrophotometer.
Table 1: Reported prevalence of PCV2 in wild boars and domestic pigs in different countries.
Country Pig breed Year Method Total number % Reference
Bavaria, Germany domestic 2016 real-time PCR 198 sows590 piglets 
0.65
0 Eddicks et al., 2016 [19]
Europe# domestic 2016 real-time 202 54
Spain domestic real-time PCR 75 PVC2-SD*12 PDNS**
92
92 Olvera et al., 2004 [20]
Slovakia domestic 2011 real-time PCRimmunofluorescence
54
35 Csank et al.,2011 [21]
Slovakia wild boars 2014 real-time PCRimmunofluorescence 51
37
49 Bhide et al., 2014 [22]
Brasil wild boars 2013 immunofluorescence 2305 84.9 Barbosa et al.,  2016 [23]
Poland domestic 2012 real-time PCR 312 75.6 Fabisiak et al.,  2012 [24]
Bavaria, Germany wild boar 2012 real-time PCRELISA 203
50.7
56 Hammer et al.,  2012 [25]
Transylvania wild boar 2010 real-time PCR 469 13.5 Cadar et al., 2010 [26]







Shen, et al., 2010 [27]




100 Reiner et al., 2010 [28]
Japan domestic 2010 real-time PCR 29 100
+
100 Sasaki et al., 2010 [29]
# Animals from five European countries, from 3% to 95% in different farms
* Pigs suffering from PCV2 systemic disease (post weaning wasting syndrome)
** Pigs suffering from porcine dermatitis and nephropathy syndrome
*** % DNA positive/ % antibody positive
+ 120 days after weaning
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A PCR was performed as described using the primers 
specific for PCV1 or PCV2 (Table 2), [17] with 150 ng DNA 
in a 25 µl volume (1 mM of each primer, 2 mM MgCl2, 10xPCR 
buffer (Thermo Fisher, Schwerte, Germany), 200 mM dNTPs, 
0.75 U AmpliTaq Gold polymerase (Thermo Fisher, Schwerte, 
Germany), 5% DMSO). Cycling parameters were 95°C for 12 min 
and 42 cycles of 20 s at 95°C for denaturation optimal annealing 
temperature of primers for 20s and elongation for 45s at 72°C, 
followed by a final step at 72°C for 10min.Porcine GAPDH was 
used as reference gene. The PCR method for the detection of 
porcine GAPDH (for primers see Table (2)) was performed using 
the Go Taq Green Master mix (Promega, Fitchburg, USA), 1 µl of 
each primer (10 µM), 150 ng DNA and water in a total reaction 
volume of 25 µl. Amplification was performed for 2 min at 95°C 
and then cycled 45 times through 30s denaturation at 95°C, 
30s at 57°C and extension for 40s at 72°C depending, followed 
by an extension step for 5 min at 72°C. A 1% agarose and the 
Gene Ruler™ 100 bp DNA ladder (Thermo Scientific, Schwerte, 
Germany) were used for gel electrophoresis. The sensitivity of the 
PCR was determined using the PCV2 plasmid PCV2Ori_pcdna3 
(courtesy Dr. A. Mankertz, Robert Koch Institute) and estimated 
as 100 copies.
RESULTS
Prevalence of PCV2 in minipigs
First, DNA isolated from liver samples or sera from Göttingen 
Minipigs were tested for PCV2 (Figure 1). As expected, a 415bp 
band was detected in some cases and altogether 14% of the 
Göttingen Minipigs were found PCV2-positive. Second, DNA 
isolated from the liver or the spleen from Aachen Minipigs, 
a new breed founded and described only recently [11] were 
screened. When the PCV2-specific PCR was performed with DNA 
from Aachen Minipigs, in addition to the expected specific band 
Table 2: Primers used in this study.























Duvigneau et al., 
2005 [30]
PCV1: Porcine Circovirus 1; fw: forward, rev: reverse; PCV2, Porcine Circovirus 2; Pgapdh: porcine glyceraldehyde 3-phosphate dehydrogenase.
Figure 1 Results of the PCR analysis of DNA from different pigs. The 415 bp bands indicate the positive animals, their number is in bold. The GAPDH control verifies 
the presence of DNA.
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Figure 2 Comparison of PCV2 sequences amplified from DNA from Göttingen/Aachen Minipigs with published sequences. The accession numbers are indicated: 
KT868370.1, which is isolate USA/OK-003/2005; AF201305, AF201306, and AF201307, which are German isolates (GER1, GER2 and GER3); Y09921 is a German PCV1 
isolate. Virus sequences 168,167were from Aachen Minipigs, all others from Göttingen Minipigs. The primer binding sites are framed.
(415bp), additional bands were observed (Figure 1). However, 
sequencing of the amplicons demonstrated that only the 415bp 
bands, but not the others, represented PCV2 (Figure 2). Altogether, 
50% of the Aachen Minipigs were found PCV2-positive. When 
the amplicons of the PCR reaction were sequenced, differences 
between the sequences of the viruses in the Aachen Minipigs and 
that from the Göttingen minipig were detected. The viruses from 
the Aachen Minipigs are more closely to an US American isolate, 
the viruses from the Göttingen Minipigs are more closely to 
previously sequence German isolates (Figure 2). The sequence of 
PCV1 is different (Figure 2) and when primers specific for PCV1 
were used in a PCR analysis, in none of the tested animals PCV1 
was detected (not shown).
Prevalence of PCV2 in genetically modified pigs
When genetically modified pigs generated for application in 
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xenotransplantation were screened for PCV2 and of PCV1, these 
viruses were not detected in all samples tested, including samples 
from the spleen or from whole blood (Figure 1), (Table 3). The 
animals were expressing one transgene such as INSLEA29Y in 
order to prevent rejection of the transplanted islet cells [14], 
or several transgenes such as the complement regulatory genes 
CD55, CD46, and CD59, the heme oxygenase HO1 and A20 in 
combination with knock-outs of enzymes responsible for the 
expression of α-Gal and Neu5Gc sugar epitopes on the cell surface 
[12]. Other genetically modified pigs, which had a GalT-KO and 
were expressing human CD46 and human thrombomodulin, had 
been used for orthotopic heart transplantation [15,16]. All these 
animals were free of PCV2 since they were vaccinated.
Prevalence of PCV2 in farm animals
In order to evaluate the prevalence of PCV2 in farm animals 
for meat production, slaughterhouse pigs and pigs in a German 
farm were analysed. DNA was isolated from the blood of the 
animals and tested. Interestingly, all animal were found negative 
for PCV2, indicating that they were vaccinated. They were also 
negative for PCV1. 
DISCUSSION
Here genetically modified animals generated in Germany for 
application in xenotransplantation and pigs for meat production 
were screened for the prevalence of PCV1 and PCV2. Since the 
genetically modified pigs were vaccinated, no PCV2 was found 
in these animals, which already had been used in preclinical 
islet cell transplantations and heart transplantations into non-
human primates [14-16]. This is the first report describing 
screening for PCV2 in genetically modified pigs generated for 
xenotransplantation. Until now mainly wild boars and domestic 
pigs in Europe, Japan and Brazil were analysed using different 
methods and PCV2 was found in 0.65 to 100% of the animals 
(Table 1). 
The fact that Göttingen Minipigs were infected with PCV2 was 
surprising, since these animals are kept under highly hygienic 
SPF conditions and were introduced into the facility by Caesarean 
delivery. However, data showing transplacental transmission of 
PCV2 [18] may explain how the virus was introduced into the 








Aachen minipig 11/22 50
Göttingen minipig 3/21 14
Genetically modified pigs 0/6 0
Genetically modified 
pigs for islet cell 
transplantation,
non-modified controls














facility. The Aachen minipigs are a newly established breed and 
are kept still not under SPF conditions. Most importantly, in both 
strains, Göttingen and Aachen minipigs, PCV2 can be eliminated 
by vaccination. That vaccination is successful can be seen in the 
other groups, where vaccination was performed and all animal 
were PCV2-negative.
Although PCV2 can infect human cells [5], no transmission of 
PCV was observed when vaccination of children with a rotavirus 
vaccine contaminated with circoviruses was performed [6,7]. 
However, it is still unknown what may happen when PCV infect 
immune suppressed humans.
Therefore, animals produced for xenotransplantation should 
be vaccinated before entering a SPF facility, animals should be 
analysed using highly sensitive detection methods and negative 
animals should be selected. Once the animals are in a SPF facility 
and PCV2 negative, vaccination will be not be required anymore.
CONCLUSION
The world-wide first screening of genetically modified pigs 
generated specifically for xenotransplantation showed that the 
animals were not infected with PCV1 and PCV2, obviously because 
they were vaccinated. On the other hand, Göttingen Minipigs 
already used in pig to non-human primate xenotransplantation 
were infected with PCV2 despite the fact that they are produced 
in a SPF facility. PCV can be eliminated from pig herds using 
sensitive detection methods, vaccination and isolation of the 
animals.
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